Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).

Conditions

• Long COVID

Interventions

• DRUG: Maraviroc (MVC)
• DRUG: Atorvastatin, 10mg, 20mg, 40mg
• DRUG: Placebo, Maraviroc
• DRUG: Placebo, Atorvastatin

Sponsor

HealthBio, Inc.